Probiotics for the prevention and treatment of oral mucositis in chemotherapy and radiotherapy: A meta-review

Main Article Content

Jaime Plazas-Román
Mauricio Guerrero-Román
Gennys Gutiérrez-Ramírez
Lenin Torres-Osorio
Antonio Díaz-Caballero

Abstract

Introduction: Oral mucositis is a common and painful complication of cancer treatment that significantly affects patients' quality of life. Objective: To determine the efficacy of probiotics in preventing and treating oral mucositis in cancer patients undergoing chemotherapy or radiotherapy. Method: A meta-review was conducted following PRISMA guidelines. Articles published between 2019 and 2024 were searched in four databases. Results: Probiotics significantly reduced the incidence of oral mucositis (RR = 0.84) and severe oral mucositis (RR = 0.65). Multi-strain probiotics were more effective than single-strain ones, with greater efficacy observed in Asian populations. Conclusions: Probiotics are a promising strategy for preventing and treating oral mucositis in cancer patients, significantly reducing its incidence and severity. Further studies are needed to optimize strain selection, establish optimal doses and durations, and understand mechanisms of action across diverse populations and cancer types.

Downloads

Download data is not yet available.

Article Details

How to Cite
Plazas-Román, J., Guerrero-Román, M., Gutiérrez-Ramírez, G., Torres-Osorio, L., & Díaz-Caballero, A. (2024). Probiotics for the prevention and treatment of oral mucositis in chemotherapy and radiotherapy: A meta-review. Duazary, 21(3), 227–237. https://doi.org/10.21676/2389783X.6099
Section
Review
Author Biographies

Jaime Plazas-Román, Universidad del Sinú Elías Bechara Zainúm, Seccional Cartagena,

Dentist from Universidad de Cartagena. MSc in Bioinformatics from Universidad Tecnológica de Bolívar. Specialist in Pediatric Dentistry and Maxillary Orthopedics from Universidad de Cartagena. Professor at Universidad del Sinú Elías Bechara Zainúm, Cartagena. Professor at Universidad de Cartagena. Professor at Corporación Universitaria Rafael Núñez.

Mauricio Guerrero-Román, Universidad del Sinú Elías Bechara Zainúm, Seccional Cartagena

Physician from Universidad del Norte. Specialist in Pediatrics from Universidad de Cartagena. Director of Pediatrics Postgraduate Program at Universidad del Sinú - Elías Bechara Zainúm, Cartagena. President of the Colombian Society of Pediatrics.

 

Gennys Gutiérrez-Ramírez, Universidad del Sinú Elías Bechara Zainúm, Seccional Cartagena

Physician from Universidad del Sinú, EBZ, Cartagena. School of Medicine. Pediatrics Program. Universidad del Sinú - Elías Bechara Zainúm, Cartagena, Colombia.

 

Lenin Torres-Osorio, Universidad del Sinú Elías Bechara Zainúm, Seccional Cartagena

Dentist from Universidad de Cartagena. Master's in Bioinformatics from Universidad Tecnológica de Bolívar. Specialist in Stomatology and Oral Surgery from Universidad de Cartagena. Professor at the School of Dentistry, Universidad del Sinú - Elías Bechara Zainúm, Cartagena, Colombia. Professor at Universidad de Cartagena.

Antonio Díaz-Caballero, Universidad de Cartagena

Dentist from Universidad de Cartagena. Ph.D. in Biomedical Sciences. Specialist in Periodontics from Pontificia Universidad Javeriana. Master's in Education from Universidad Del Norte. Professor at Universidad de Cartagena. Leader of the GITOUC research group.

References

Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126:4423–431. https://doi.org/10.1002/cncr.33100

Bruno JS, Al-Qadami GH, Laheij AMGA, Bossi P, Fregnani ER, Wardill HR. From pathogenesis to intervention: The importance of the microbiome in oral mucositis. Int J Mol Sci. 2023;24:8274. https://doi.org/10.3390/ijms24098274

Cinausero M, Aprile G, Ermacora P, Basile D, Vitale MG, Fanotto V, et al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front Pharmacol. 2017;8:354. https://doi.org/10.3389/fphar.2017.00354

Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:1-28. https://doi.org/10.1038/s41392-022-00974-4

Anderson PM, Thomas SM, Sartoski S, Scott JG, Sobilo K, Bewley S, et al. Strategies to mitigate chemotherapy and radiation toxicities that affect eating. Nutrients. 2021;13:4397. https://doi.org/10.3390/nu13124397

Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A, et al. Oral mucositis: The hidden side of cancer therapy. J Exp Clin Cancer Res. 2020;39:210. https://doi.org/10.1186/s13046-020-01715-7.

Mucositis. Cleveland Clinic. Cleveland: Cleveland Clinic; 2024.

Al-Rudayni AHM, Gopinath D, Maharajan MK, Menon RK. Impact of oral mucositis on quality of life in patients undergoing oncological treatment: A systematic review. Transl Cancer Res. 2020;9:5269-83. https://doi.org/10.21037/tcr.2020.02.77

Franco R, Lupi E, Iacomino E, Galeotti A, Capogreco M, Santos JMM, et al. Low-Level Laser Therapy for the Treatment of Oral Mucositis Induced by Hematopoietic Stem Cell Transplantation: A Systematic Review with Meta-Analysis. Medicina. 2023;59:1413. https://doi.org/10.3390/medicina59081413

Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545-602. https://doi.org/10.1016/S0140-6736(16)31678-6

Zawrzykraj M, Deptuła M, Kondej K, Tymińska A, Pikuła M. The effect of chemotherapy and radiotherapy on stem cells and wound healing. Current perspectives and challenges for cell-based therapies. Biomed Pharmacother. 2023;168:115781. https://doi.org/10.1016/j.biopha.2023.115781

Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022;72:57-77. https://doi.org/10.3322/caac.21704

Bell A, Kasi A. Oral Mucositis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Singh V, Singh AK. Oral mucositis. Natl J Maxillofac Surg. 2020;11:159-68. https://doi.org/10.4103/njms.NJMS_10_20

Thomsen M, Vitetta L. Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis. Integr Cancer Ther. 2018;17:1027-47. https://doi.org/10.1177/1534735418794885

Wang Z, Li L, Wang S, Wei J, Qu L, Pan L, et al. The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy. Front Pharmacol. 2022;13:1025860. https://doi.org/10.3389/fphar.2022.1025860

Khosroshahi RA, Zeraattalab-Motlagh S, Sarsangi P, Nielsen SM, Mohammadi H. Effect of probiotic supplementation on chemotherapy- and radiotherapy-related diarrhoea in patients with cancer: an umbrella review of systematic reviews and meta-analyses. Br J Nutr. 2023;130:1754-65. https://doi.org/10.1017/S0007114523000910

Venkateswaramurthy N, S A, R EP. Managing Chemotherapy-Induced Diarrhea: Efficacy of Interventions for Cancer Patients. Biosci Biotechnol Res Asia. 2024;21:121-8.

Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023;8:1-27. https://doi.org/10.1038/s41392-023-01406-7

Legesse Bedada T, Feto TK, Awoke KS, Garedew AD, Yifat FT, Birri DJ. Probiotics for cancer alternative prevention and treatment. Biomed Pharmacother. 2020;129:110409. https://doi.org/10.1016/j.biopha.2020.110409

Martín R, Langella P. Emerging health concepts in the probiotics field: Streamlining the definitions. Front Microbiol. 2019;10:1047. https://doi.org/10.3389/fmicb.2019.01047

Dahiya D, Nigam PS. Biotherapy using probiotics as therapeutic agents to restore the gut microbiota to relieve gastrointestinal tract inflammation, IBD, IBS and prevent induction of cancer. Int J Mol Sci. 2023;24:5748. https://doi.org/10.3390/ijms24065748

Yunes RA, Poluektova EU, Belkina TV, Danilenko VN. Lactobacilli: Legal Regulation and Prospects for New Generation Drugs. Appl Biochem Microbiol. 2022;58:652-64. https://doi.org/10.1134/S0003683822050179

Maftei NM, Raileanu CR, Balta AA, Ambrose L, Boev M, Marin DB, et al. The potential impact of probiotics on human health: An update on their health-promoting properties. Microorganisms. 2024;12:234. https://doi.org/10.3390/microorganisms12020234

Brown TJ, Gupta A. Management of cancer therapy–associated oral mucositis. JCO Oncol Pract. 2020;16:103-9. https://doi.org/10.1200/JOP.19.00652

Feng J, Gao M, Zhao C, Yang J, Gao H, Lu X, et al. Oral administration of probiotics reduces chemotherapy-induced diarrhea and oral mucositis: A systematic review and meta-analysis. Front Nutr. 2022;9:823288. https://doi.org/10.3389/fnut.2022.823288

Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 2023;12:184. https://doi.org/10.3390/cells12010184

Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Multi-strain probiotics: Synergy among isolates enhances biological activities. Biology. 2021;10:322. https://doi.org/10.3390/biology10040322

Jiang C, Wang H, Xia C, Dong Q, Chen E, Qiu Y, et al. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. Cancer. 2019;125:1081-90. https://doi.org/10.1002/cncr.31907

Naeem H, Hassan HU, Shahbaz M, Imran M, Memon AG, Hasnain A, et al. Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies. Journal of Food Biochemistry. 2024;2024: e6632209. https://doi.org/10.1155/2024/6632209

Liu YC, Wu CR, Huang TW. Preventive effect of probiotics on oral mucositis induced by cancer treatment: A systematic review and meta-analysis. Int J Mol Sci. 2022;23:13268. https://doi.org/10.3390/ijms232113268

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Rev Esp Cardiol. 2021;74:790-9. https://doi.org/10.1016/j.recesp.2021.06.016

Santos CM da C, Pimenta CA de M, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15:508–511. https://doi.org/10.1590/S0104-11692007000300023

Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: An introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18:2127-33. https://doi.org/10.11124/JBISRIR-D-19-00099

Resolución 8430 de 1993 - Colombia. Bogotá: Ministerio de Salud; 1993.

Minervini G, Franco R, Marrapodi MM, Fiorillo L, Badnjević A, Cervino G, et al. Probiotics in the treatment of radiotherapy-induced oral mucositis: Systematic review with meta-analysis. Pharmaceuticals. 2023;16:654. https://doi.org/10.3390/ph16050654

Shu Z, Li P, Yu B, Huang S, Chen Y. The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis. Oral Oncology. 2020;102:104559. https://doi.org/10.1016/j.oraloncology.2019.104559.

Allenby TH, Crenshaw ML, Mathis K, Champ CE, Simone NL, Schmitz KH, et al. A systematic review of home-based dietary interventions during radiation therapy for cancer. Tech Innov Patient Support Radiat Oncol. 2020;16:10-6. https://doi.org/10.1016/j.tipsro.2020.08.001

Lipták L, Szabó K, Nagy G, Márton S, Madléna M. Microbiological Changes and Caries-Preventive Effect of an Innovative Varnish Containing Chlorhexidine in Orthodontic Patients. Caries Res. 2018;52:272-8. https://doi.org/10.1159/000486140

DE Sanctis V, Belgioia L, Cante D, LA Porta MR, Caspiani O, Guarnaccia R, et al. Lactobacillus brevis CD2 for prevention of oral mucositis in patients with head and neck tumors: A multicentric randomized study. Anticancer Res. 2019;39:1935-42. https://doi.org/10.21873/anticanres.13303

Matera M. Bifidobacteria, Lactobacilli... when, how and why to use them. Global Pediatrics. 2024;8:100139. https://doi.org/10.1016/j.gpeds.2024.100139

Bruno G. Popular probiotics: The latest on Lactobacilli and Bifidobacteria. Nutritional Outlook. 2022.

Papizadeh M, Rohani M, Nahrevanian H, Javadi A, Pourshafie MR. Probiotic characteristics of Bifidobacterium and Lactobacillus are a result of the ongoing gene acquisition and genome minimization evolutionary trends. Microb Pathog. 2017;111:118-31. https://doi.org/10.1016/j.micpath.2017.08.021

Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction. Radiat Oncol. 2021;16:9. https://doi.org/10.1186/s13014-020-01735-9

López-Gómez L, Alcorta A, Abalo R. Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review. J Pers Med. 2023;13:1487. https://doi.org/10.3390/jpm13101487

Hashemi B, Abdollahi M, Abbaspour-Aghdam S, Hazrati A, Malekpour K, meshgi S, et al. The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis. Biomed Pharmacother. 2023;159:114195. https://doi.org/10.1016/j.biopha.2022.114195

Rau S, Gregg A, Yaceczko S, Limketkai B. Prebiotics and Probiotics for Gastrointestinal Disorders. Nutrients. 2024;16:778. https://doi.org/10.3390/nu16060778

Ren Y, Wu J, Wang Y, Zhang L, Ren J, Zhang Z, et al. Lifestyle patterns influence the composition of the gut microbiome in a healthy Chinese population. Sci Rep. 2023;13:14425. https://doi.org/10.1038/s41598-023-41532-4

Thu MS, Ondee T, Nopsopon T, Farzana IAK, Fothergill JL, Hirankarn N, et al. Effect of probiotics in breast cancer: A systematic review and meta-analysis. Biology. 2023;12:280. https://doi.org/10.3390/biology12020280

Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne I, et al. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol. 2020;9:454. https://doi.org/10.3389/fcimb.2019.00454

Most read articles by the same author(s)